1887

Abstract

SUMMARY

Monoclonal antibodies (MAbs) against the Asibi wild-type strain of yellow fever (YF) virus were prepared and characterized. One of the MAbs (designated MAb 117) was shown, by cross-immunofluorescence tests with flaviviruses, to be specific for wild-type YF virus. This MAb was used in indirect immunofluorescence tests to identify wild-type antigenic variants in several different YF vaccine pools. Simultaneously, a vaccine-specific MAb prepared previously (MAb 864) was used to identify YF strain 17D vaccine type variants in the wild-type Asibi virus preparation. One variant, isolated by plaque purification from a 17D vaccine pool, possessed the wild-type epitope and was neurovirulent in infant mice whereas other variants, lacking the wild-type epitope but with vaccine-specific epitopes (identified by MAb 411), were avirulent in infant mice. Avirulent variants were able to infect mice and induce antibody. Virus-specific antigen was still detected in the brains of these mice 4 weeks after inoculation, suggesting that persistent infections were developing. These results demonstrate the antigenic heterogeneity of 17D vaccine preparations. They also point to the potential risk of selection of wild-type variants in YF vaccine preparations and re-emphasize the need for modernization of techniques and more effective control measures to be taken during the production of YF vaccine.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-70-7-1889
1989-07-01
2022-01-24
Loading full text...

Full text loading...

/deliver/fulltext/jgv/70/7/JV0700071889.html?itemId=/content/journal/jgv/10.1099/0022-1317-70-7-1889&mimeType=html&fmt=ahah

References

  1. Barrett A. D. T., Gould E. A. 1986; Comparison of neurovirulence of different strains of yellow fever virus in mice. Journal of General Virology 67:631–637
    [Google Scholar]
  2. Buckley A., Gould E. A. 1985; Neutralization of yellow fever virus studied using monoclonal and polyclonal antibodies. Journal of General Virology 66:2523–2531
    [Google Scholar]
  3. Cammack N., Gould E. A. 1986; Topographical analysis of epitope relationships on the envelope glycoprotein of yellow fever 17D vaccine and the wild type Asibi parent virus. Virology 150:333–341
    [Google Scholar]
  4. Cane P. A., Gould E. A. 1989; Immunoblotting reveals differences in the accumulation of envelope protein by wild-type and vaccine strains of yellow fever virus. Journal of General Virology 70:557–564
    [Google Scholar]
  5. Gould E. A., Buckley A., Cammack N. 1985a; Use of the biotin–streptavidin interaction to improve flavivirus detection by immunofluorescence and ELISA tests. Journal of Virological Methods 11:41–48
    [Google Scholar]
  6. Gould E. A., Buckley A., Cammack N., Barrett A. D. T., Clegg J. C. S., Ishak R., Varma M. G. R. 1985b Examination of the immunological relationships between flaviviruses using yellow fever virus monoclonal antibodies. Journal of General Virology 66:1369–1382
    [Google Scholar]
  7. Karabatsos N. 1985 International Catalogue of Arboviruses, 3. San Antonio: American Society of Tropical Medicine and Hygiene;
    [Google Scholar]
  8. Liprandi F. 1981; Isolation of plaque variants differing in virulence from the 17D strain of yellow fever virus. Journal of General Virology 56:363–370
    [Google Scholar]
  9. Mathis E., Sellards A. S., Leigret S. 1928; Sensibilite du Macacus rhesus au virus de la fievre jaune. Compte rendu hebdomadaire des séances de l‘ Académie des sciences 186:604–606
    [Google Scholar]
  10. Monath T. P., Kinney R. M., Schlesinger J. J., Brandris M. W, Brès P. 1983; Ontogeny of yellow fever 17D vaccine: RNA oligonucleotide fingerprint and monoclonal antibody analysis of vaccines produced worldwide. Journal of General Virology 64:627–637
    [Google Scholar]
  11. Pan American Health Organization; 1984 Report of the Pan American Health Organization: Meeting to Develop Guidelines and Protocols for the Production of Yellow Fever Vaccine in Cell Cultures Washington, D.C.:21–23February
    [Google Scholar]
  12. Porterfield J. S. 1980; Antigenic characteristics and classification of Togaviridae. In The Togaviruses13–42 Schlesinger R. W. New York & London: Academic Press;
    [Google Scholar]
  13. Theiler M. 1951; The virus. In Yellow Fever39–136 Strode G. P. New York: McGraw-Hill;
    [Google Scholar]
  14. Theiler M., Smith H. H. 1937; Effect of prolonged cultivation in vitro upon pathogenicity of yellow fever virus. Journal of Experimental Medicine 65:767–786
    [Google Scholar]
  15. Woodall J. P. 1981; Summary of a symposium on yellow fever. Journal of Infectious Diseases 144:87–91
    [Google Scholar]
  16. WORLD HEALTH ORGANIZATION; 1981 Technical Report Series658
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-70-7-1889
Loading
/content/journal/jgv/10.1099/0022-1317-70-7-1889
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error